|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005910,
umls-concept:C0015127,
umls-concept:C0019139,
umls-concept:C0178602,
umls-concept:C0205419,
umls-concept:C0231441,
umls-concept:C0237401,
umls-concept:C0443218,
umls-concept:C1314792,
umls-concept:C1707520,
umls-concept:C2827483
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-1-13
|
|
pubmed:abstractText |
Low-molecular-weight heparins (LMWHs) are routinely given without the control of their effect on coagulation. The endogenous thrombin potential (ETP) is a sensitive detector of the heparin effect.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1538-7933
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
83-9
|
|
pubmed:dateRevised |
2010-3-29
|
|
pubmed:meshHeading |
pubmed-meshheading:16409456-Adolescent,
pubmed-meshheading:16409456-Adult,
pubmed-meshheading:16409456-Antithrombin III,
pubmed-meshheading:16409456-Blood Coagulation,
pubmed-meshheading:16409456-Blood Coagulation Tests,
pubmed-meshheading:16409456-Body Weight,
pubmed-meshheading:16409456-Dose-Response Relationship, Drug,
pubmed-meshheading:16409456-Drug Evaluation,
pubmed-meshheading:16409456-Factor Xa,
pubmed-meshheading:16409456-Heparin, Low-Molecular-Weight,
pubmed-meshheading:16409456-Humans,
pubmed-meshheading:16409456-Male,
pubmed-meshheading:16409456-Molecular Weight,
pubmed-meshheading:16409456-Reproducibility of Results,
pubmed-meshheading:16409456-Thrombophilia
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly correlated to body weight.
|
|
pubmed:affiliation |
Synapse BV, Cardiovascular Research Institute, Maastricht, The Netherlands. r.aldieri@thrombin.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
